Thymosin Beta 4 (Tβ4) is a 43-amino acid peptide that is one of the most abundant naturally occurring peptides in the human body. It is found in nearly all tissues and cell types and plays a critical role in tissue repair, cell migration, and wound healing.
Tβ4 works primarily by sequestering actin monomers, which regulates cell motility and enables cells to migrate to sites of injury. It also has significant anti-inflammatory and anti-fibrotic properties.
Thymosin Beta 4 is not FDA-approved for medical use. It has been studied in clinical trials for corneal wound healing and cardiac repair. It is available through compounding pharmacies and used off-label in peptide therapy clinics.
Clinical evidence in humans is emerging, with most robust data in corneal and cardiac applications.
Thymosin Beta 4 exerts its effects through multiple pathways:
Clinical trial demonstrating improved corneal wound healing with topical Thymosin Beta 4 application.
Study showing Tβ4 promoted cardiac cell migration and survival after myocardial injury in animal models.
Comprehensive review of Tβ4's role in wound healing, angiogenesis, and anti-inflammatory activity across tissue types.
If you're using a browser with advanced ad blocking security measures, the above study links may not work. You can copy the link and paste it into a new window.
Disclaimer: The information on this page was generated with the assistance of artificial intelligence and compiled from publicly available sources. While efforts are made to ensure accuracy, information may be incomplete, outdated, or incorrect and should not be relied upon as medical advice.
R2 Medical Clinic uses medications sourced from compounding pharmacies. Compounded drugs have not been approved by the FDA; have not been reviewed by the FDA for safety, efficacy, or quality; and have not been demonstrated to the FDA to be safe or effective for their intended use. The processes by which the compounded drugs are manufactured have not been reviewed by the FDA. FDA approved products containing semaglutide and tirzepatide are available.